Chronic wounds represent a major global health challenge that has been termed a “silent epidemic” due to its significant but often unrecognized impact.
Unlike acute wounds that heal within days or weeks, chronic wounds fail to progress through the normal healing sequence, persisting for months or even years. This silent epidemic affects millions worldwide, with staggering economic costs and profound impacts on patient quality of life.
The unique pathophysiology of chronic wounds involves a complex hijacking of the body’s natural healing processes, particularly through persistent inflammation and cellular dysfunction.
Normal Wound Healing
The foundation for understanding chronic wound pathology lies in recognizing how normal wound healing should progress. Wound healing is a remarkably orchestrated process that occurs through distinct yet overlapping phases.
The Healing Cascade
When skin is injured, a complex cascade of cellular and molecular events is immediately activated. The process begins with hemostasis, where blood vessels constrict and platelets aggregate to form a clot3. This initial phase is followed by inflammation, characterized by the infiltration of neutrophils and macrophages that clear debris and fight potential infection 35.
The inflammatory phase typically transitions to the proliferative phase within days of injury. During proliferation, keratinocytes become activated by changes in mechanical tension, electrical gradients, and exposure to hydrogen peroxide, pathogens, growth factors, and cytokines 3 13. These activated keratinocytes undergo partial epithelial-mesenchymal transition, developing a more migratory phenotype to reform the epidermal layer through re-epithelialization 13.
Simultaneously, fibroblasts proliferate and migrate into the wound, where they synthesize collagen and other extracellular matrix components 37. Angiogenesis—the formation of new blood vessels—occurs as endothelial cells proliferate in response to hypoxia and growth factors like Vascular Endothelial Growth Factor (VEGF)710.
The final remodeling phase can continue for months or even years, as the wound undergoes maturation. The extracellular matrix is continuously modified, with a fine balance between degradation and synthesis regulated by matrix metalloproteinases (MMPs) and their inhibitors 37.
Cellular Orchestra of Healing
Normal wound healing requires precise coordination among multiple cell types. Neutrophils, which arrive early after injury, remove necrotic tissue and pathogens through phagocytosis and the release of reactive oxygen species (ROS), antimicrobial peptides, and proteolytic enzymes 3. They also form neutrophil extracellular traps (NETs) to capture and kill pathogens 3.
Macrophages play a pivotal role in orchestrating the transition from inflammation to repair. They undergo a critical phenotypic shift from pro-inflammatory (M1) macrophages in the early stages to anti-inflammatory (M2) macrophages as healing progresses 5 7 10. This polarization switch is essential for resolving inflammation and initiating tissue repair 10.
Fibroblasts transform into myofibroblasts under the influence of TGF-β and mechanical tension 3. These specialized cells contain alpha-smooth muscle actin (α-SMA), giving them strong contractile abilities that help pull the wound edges together 3. The coordinated apoptosis of these cells marks the completion of wound healing and prevents excessive scarring 7.
The Chronic Wound Crisis
Chronic wounds represent a growing public health concern with far-reaching implications for patients and healthcare systems worldwide.
Defining the Challenge
A chronic wound is defined as one that fails to progress through the normal, orderly, and timely sequence of repair, or in which the repair process fails to restore anatomic and functional integrity after three months4. Wounds that do not heal within four weeks are often considered chronic, and in many cases, they may never heal or may take years to do so 1.
The prevalence of chronic wounds is staggering, affecting an estimated 1.5-2 million people across Europe and around 6.5 million people in the USA at any given time 9. A 2012 German study found a 1-2% prevalence of chronic non-healing wounds in the general population 4. These numbers are expected to rise with aging populations and increasing rates of diabetes and obesity 1 12.
Economic and Human Toll
The economic burden of chronic wounds is enormous. In 2014, wound care for Medicare beneficiaries alone cost an estimated $28 billion to $96.8 billion 4. In the UK, chronic wounds cost the NHS approximately £8.3 billion each year in staff costs, wound dressings, and medication 12.
Beyond financial costs, the human toll is profound. For patients with chronic wounds, the impact on their lives can be devastating. They often experience anxiety and distress from prolonged suffering 1. If not properly treated, these wounds can lead to severe infections, hospitalization, amputations, and in the worst cases, death1. The five-year mortality rate after developing a diabetic ulcer is approximately 40%, highlighting the serious nature of this condition 4.
Chronic wounds preceded 85% of amputations, predominantly in diabetic patients 4. Singapore has one of the world’s highest rates of amputations, with more than four diabetic lower limb amputations occurring every day 1. This emphasizes the global nature of this silent epidemic and its severe consequences.
How Chronic Wounds Hijack Healing
In chronic wounds, the normal healing process becomes derailed, with multiple cellular and molecular mechanisms effectively “hijacked” to perpetuate a non-healing state.
The Inflammatory Trap
The hallmark of chronic wounds is their inability to progress beyond the inflammatory phase 5 8 10. While acute inflammation is essential for clearing debris and fighting infection, chronic inflammation becomes destructive. Chronic wounds are characterized by high numbers of Langerhans cells, neutrophils, and pro-inflammatory macrophages 5.
This persistent inflammation creates a cycle of tissue damage and repair attempts that never resolve. Neutrophils in chronic wounds are excessively primed to produce neutrophil extracellular traps, which, while designed to trap pathogens, can be cytotoxic to host cells and delay healing 5. In diabetic wounds, neutrophils show increased resistance to apoptosis and are less effectively cleared by macrophages, further perpetuating inflammation 5.
The conversion from pro-inflammatory “M1” to anti-inflammatory “M2” macrophages—an essential step for transitioning from inflammation to proliferation—fails to occur in chronic wounds 10. This prevents the shift to the reparative phase of healing, essentially trapping the wound in a continuous cycle of inflammation 5 10.
Cellular Dysfunction
Chronic wounds exhibit widespread cellular dysfunction across multiple cell types critical for healing:
Fibroblasts in chronic wounds show impaired physiology, with decreased migration, proliferation, and collagen production, particularly in response to hypoxia 11. This compromises the formation of new extracellular matrix essential for wound closure.
Keratinocytes, responsible for re-epithelialization, demonstrate aberrant activation in chronic wounds, leading to hyperproliferation but paradoxically impaired migration 3. This prevents effective coverage of the wound surface.
Macrophages in diabetic wounds exhibit defective efferocytosis (clearance of apoptotic cells), impaired phagocytosis of bacteria, and reduced ability to polarize to an anti-inflammatory state5. Even before ulceration, the skin of diabetic humans and mice exhibits higher numbers of macrophages primed to the pro-inflammatory state 5.
Molecular Imbalances
At the molecular level, chronic wounds display significant imbalances that perpetuate the non-healing state:
Matrix metalloproteinases (MMPs) are excessively active in chronic wounds, leading to the degradation of newly formed extracellular matrix and destruction of growth factors necessary for healing 38. This proteolytic environment creates a hostile microenvironment that impedes healing.
Pro-inflammatory cytokines, including interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), are persistently elevated in chronic wounds 3 5 8. These cytokines maintain the inflammatory state and prevent progression to the proliferative phase.
In diabetic wounds, glycosylation of collagen impairs its structure and function11. Despite upregulation of type I collagen gene expression, there is inadequate synthesis of fully functional collagen molecules in the wound, compromising extracellular matrix formation 11.
The Infection Connection
Many chronic wounds harbor bacteria that form biofilms—complex communities of microorganisms embedded in a protective matrix 8 12. These biofilms are resistant to both host defense mechanisms and antibiotics, contributing to persistent inflammation and impaired healing 8 12.
The presence of biofilms creates a continuous cycle of infection, inflammation, and inadequate repair, maintaining the wound in a perpetual state of non-healing 5. Statistics show that 59% of chronic wounds healed if there was no evidence of infection, compared with only 45% if infection was present or suspected 12.
Types and Causes of Chronic Wounds
Chronic wounds have diverse etiologies, but the most common types include diabetic ulcers, venous ulcers, and pressure injuries.
Diabetic Foot Ulcers
Diabetic foot ulcers represent one of the most challenging types of chronic wounds. Diabetes impacts wound healing through multiple mechanisms, including impaired blood flow, neuropathy leading to unnoticed injuries, and immune dysfunction 4 11.
At the cellular level, diabetes causes glycosylation of collagen, compromising its structure and function 11. This prevents the formation of properly functioning extracellular matrix despite active collagen gene expression. Additionally, diabetes alters macrophage function, impairing their ability to clear bacteria and shift to an anti-inflammatory phenotype 5.
Hypoxia plays a critical role in diabetic wound pathology. Reduced oxygen supply severely impairs ATP synthesis, resulting in decreased collagen production—the main pathophysiological mechanism leading to chronic wounds in these patients 11.
Venous and Pressure Ulcers
Venous ulcers develop due to venous hypertension, often resulting from venous insufficiency. The high pressure in the veins leads to fluid leakage, inflammation, and eventually tissue breakdown 4. Compression therapy has been proven beneficial for venous ulcer treatment and is considered the standard of care 4.
Pressure ulcers (also called pressure injuries or bedsores) form when persistent localized pressure restricts blood flow to tissues, leading to ischemia and tissue death 1. They commonly occur in immobile patients, particularly over bony prominences. Establishing a repositioning schedule and avoiding positioning patients on bony prominences are essential preventive measures 4.
Underlying Mechanisms
Despite their different causes, chronic wounds share common pathophysiological mechanisms:
- Persistent inflammation with excessive neutrophils and pro-inflammatory macrophages 5 8
- Imbalance between tissue degradation and synthesis, with elevated proteases 3 8 11
- Impaired cell migration and proliferation affecting multiple cell types 3 7 11
- Reduced angiogenesis and inadequate blood supply 7 10 11
- Frequent colonization with biofilm-forming bacteria 8 12
These shared mechanisms explain why diverse wounds develop similar chronic, non-healing characteristics and may require similar treatment approaches.
Diagnostic and Treatment Approaches
Effectively managing chronic wounds requires comprehensive assessment and multifaceted treatment strategies addressing the underlying causes of delayed healing.
Comprehensive Assessment
Proper diagnosis is crucial for effective management. This includes:
- Evaluating the wound’s characteristics (size, depth, appearance, exudate)
- Assessing vascular status (particularly important for diabetic and venous ulcers)
- Screening for infection or biofilm presence
- Identifying underlying medical conditions contributing to poor healing
For diabetic patients, it’s important to note that the ankle-brachial index may not be accurate; the toe-brachial index should be used instead to screen for peripheral arterial disease 4.
Addressing Underlying Causes
Treatment must address the primary etiology of the wound:
For diabetic ulcers, offloading with a total contact cast is considered the optimal treatment 4. This reduces pressure on the ulcer, allowing healing to occur. Glycemic control is also essential for improving healing potential.
Venous ulcers require compression therapy to counteract venous hypertension 4. Various compression systems are available, from bandages to specialized stockings, with selection based on patient factors and wound characteristics.
Pressure ulcers necessitate pressure redistribution and a regular repositioning schedule 4. Specialized support surfaces can help distribute pressure more evenly.
Wound Bed Preparation
Creating an optimal environment for healing is crucial:
- Debridement to remove necrotic tissue and reduce biofilm burden
- Appropriate moisture balance—contrary to traditional belief, chronic wounds heal better with moist rather than dry dressings2
- Infection control through appropriate antimicrobial therapies
- Management of excessive exudate that can macerate surrounding tissue
Advanced Therapies
For recalcitrant wounds, advanced therapies may be necessary:
Negative pressure wound therapy uses controlled suction to remove excess fluid, reduce edema, increase blood flow, and promote granulation tissue formation 6.
Skin substitutes provide a temporary or permanent covering that delivers growth factors and structural proteins to promote healing 6 12.
Hyperbaric oxygen therapy increases tissue oxygenation, which is particularly beneficial for hypoxic wounds6.
Growth factor therapies aim to supplement the wound environment with factors that stimulate cell proliferation, migration, and matrix synthesis 6 12.
Emerging Research and Future Directions
Research into chronic wound healing continues to evolve, offering new insights and therapeutic possibilities.
Immunomodulatory Approaches
Given the central role of immune dysfunction in chronic wounds, targeting the immune response represents a promising avenue for future therapies 5 7:
- Strategies to promote the transition from pro-inflammatory M1 to anti-inflammatory M2 macrophages 5 7
- Approaches to regulate neutrophil recruitment, activation, and clearance 5
- Therapies that modulate specific T cell populations to promote healing 5 7
Studies are investigating various compounds that can modulate the immune response in chronic wounds, potentially breaking the cycle of persistent inflammation.
Targeting Molecular Pathways
Research is identifying specific molecular targets for intervention:
- Inhibitors of excessive MMP activity to prevent degradation of the extracellular matrix 3 8
- Factors that promote appropriate angiogenesis in hypoxic wounds 7 10
- Molecules that enhance fibroblast and keratinocyte migration and function 3 7
These targeted approaches may provide more effective and specific interventions than current broad-spectrum treatments.
Natural Bioactive Compounds
Growing interest in natural compounds with wound-healing properties is yielding promising results8. Various plant-derived substances have demonstrated anti-inflammatory, antimicrobial, and pro-healing properties that could complement conventional treatments.
Research into these compounds is particularly valuable given concerns about antibiotic resistance and the need for multiple treatment options for complex chronic wounds.
Biofilm Management Strategies
Novel approaches to biofilm disruption and prevention are under investigation 8 12. These include specialized dressings, topical agents that penetrate biofilms, and therapies that prevent bacterial attachment and colonization.
Effective biofilm management is crucial, as statistics demonstrate significantly better healing rates in wounds without infection 12.
Conclusion
The silent epidemic of chronic wounds represents a major healthcare challenge with profound implications for patients and healthcare systems worldwide. These wounds effectively hijack the body’s natural healing machinery, becoming trapped in a state of persistent inflammation that prevents progression to the reparative phases of healing.
Understanding the complex pathophysiology of chronic wounds is crucial for developing effective treatment strategies. The interplay between immune dysfunction, cellular abnormalities, molecular imbalances, and microbial biofilms creates a challenging environment that resists healing.
Current management approaches focus on addressing underlying causes, preparing the wound bed, and providing an optimal environment for healing. Advanced therapies offer additional options for wounds that fail to respond to standard treatments.
Looking forward, emerging research in immunomodulation, molecular targeting, natural compounds, and biofilm management offers hope for more effective interventions. By continuing to advance our understanding of the mechanisms underlying chronic wounds, we can develop more targeted and effective treatments to address this silent epidemic and improve outcomes for the millions of patients affected worldwide.
Citations:
- https://www.a-star.edu.sg/News/astarNews/news/features/addressing-the-silent-epidemic-of-chronic-wounds
- https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/wounds-how-to-care-for-them
- https://royalsocietypublishing.org/doi/10.1098/rsob.200223
- https://www.aafp.org/pubs/afp/issues/2020/0201/p159.html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8150999/
- https://pubmed.ncbi.nlm.nih.gov/28108895/
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1395479/full
- https://www.mdpi.com/1422-0067/23/9/4928
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7949725/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6751250/
- https://sciendo.com/pdf/10.2478/sjecr-2018-0077
- https://pharmaceutical-journal.com/article/ld/current-and-advanced-therapies-for-chronic-wound-infection
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7536089/
- https://www.nature.com/articles/s41572-022-00377-3
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4742992/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5017042/
- https://www.sheffield.ac.uk/news/revolutionary-chronic-wound-treatment-could-help-millions
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4671308/
- https://www.coloplastprofessional.co.uk/education-library/knowledge/advanced-wound-care-knowledge/wound-healing/
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.648554/full
- https://journals.cambridgemedia.com.au/wpr/volume-26-number-2/solutions-chronic-wounds-problem-australia-call-action
- https://www.ncbi.nlm.nih.gov/books/NBK482254/
- https://www.ncbi.nlm.nih.gov/books/NBK534261/
- https://www.ncbi.nlm.nih.gov/books/NBK326436/
- https://pubmed.ncbi.nlm.nih.gov/34066746/
- https://journals.cambridgemedia.com.au/wpr/volume-25-number-2/causes-and-consideration-chronic-wounds-narrative-review-evidence
- https://www.nature.com/articles/4401632
- https://www.liebertpub.com/doi/10.1089/wound.2014.0608
- https://www.science.org/doi/10.1126/scitranslmed.3009337
- https://my.clevelandclinic.org/health/body/24894-amygdala
- https://www.nature.com/articles/s42003-024-07219-w
- https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02178/full
- https://www.admiral.com/travel-insurance
- https://www.mdpi.com/2227-9059/9/11/1611
- https://www.nice.org.uk/advice/esmpb2/chapter/key-points-from-the-evidence